WO2012112757A3 - Compositions et procédés améliorés de remplacement de tissu mou - Google Patents

Compositions et procédés améliorés de remplacement de tissu mou Download PDF

Info

Publication number
WO2012112757A3
WO2012112757A3 PCT/US2012/025412 US2012025412W WO2012112757A3 WO 2012112757 A3 WO2012112757 A3 WO 2012112757A3 US 2012025412 W US2012025412 W US 2012025412W WO 2012112757 A3 WO2012112757 A3 WO 2012112757A3
Authority
WO
WIPO (PCT)
Prior art keywords
soft tissue
compositions
tissue replacement
replacement methods
improved soft
Prior art date
Application number
PCT/US2012/025412
Other languages
English (en)
Other versions
WO2012112757A2 (fr
Inventor
Dennis E. Van Epps
Guang-Liang Jiang
Wha-Bin Im
Original Assignee
Allergan, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/193,744 external-priority patent/US8697056B2/en
Application filed by Allergan, Inc. filed Critical Allergan, Inc.
Priority to BR112013021035A priority Critical patent/BR112013021035A2/pt
Priority to EP12708198.2A priority patent/EP2675491A2/fr
Priority to AU2012217630A priority patent/AU2012217630A1/en
Priority to CA2827615A priority patent/CA2827615A1/fr
Publication of WO2012112757A2 publication Critical patent/WO2012112757A2/fr
Publication of WO2012112757A3 publication Critical patent/WO2012112757A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • A61L27/3666—Epithelial tissues other than skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3869—Epithelial tissues other than skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Sanitary Thin Papers (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne des compositions et des procédés pour traiter une anomalie d'un tissu mou d'un individu.
PCT/US2012/025412 2011-02-17 2012-02-16 Compositions et procédés améliorés de remplacement de tissu mou WO2012112757A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
BR112013021035A BR112013021035A2 (pt) 2011-02-17 2012-02-16 composições e métodos de reposição de tecido macio aperfeiçoados
EP12708198.2A EP2675491A2 (fr) 2011-02-17 2012-02-16 Compositions et procédés améliorés de remplacement de tissu mou
AU2012217630A AU2012217630A1 (en) 2011-02-17 2012-02-16 Compositions and improved soft tissue replacement methods
CA2827615A CA2827615A1 (fr) 2011-02-17 2012-02-16 Compositions et procedes ameliores de remplacement de tissu mou

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161444078P 2011-02-17 2011-02-17
US61/444,078 2011-02-17
US13/193,744 US8697056B2 (en) 2010-08-19 2011-07-29 Compositions and soft tissue replacement methods
US13/193,744 2011-07-29

Publications (2)

Publication Number Publication Date
WO2012112757A2 WO2012112757A2 (fr) 2012-08-23
WO2012112757A3 true WO2012112757A3 (fr) 2014-01-09

Family

ID=46673171

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2012/025412 WO2012112757A2 (fr) 2011-02-17 2012-02-16 Compositions et procédés améliorés de remplacement de tissu mou

Country Status (5)

Country Link
EP (1) EP2675491A2 (fr)
AU (1) AU2012217630A1 (fr)
BR (1) BR112013021035A2 (fr)
CA (1) CA2827615A1 (fr)
WO (1) WO2012112757A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8697057B2 (en) 2010-08-19 2014-04-15 Allergan, Inc. Compositions and soft tissue replacement methods
WO2013123274A1 (fr) * 2012-02-16 2013-08-22 Allergan, Inc. Compositions et procédés perfectionnés de remplacement de tissu mou
WO2013123272A1 (fr) * 2012-02-16 2013-08-22 Allergan, Inc. Compositions et procédés perfectionnés de remplacement de tissu mou
CA3175025A1 (fr) * 2020-03-25 2021-09-30 Fukuoka University Agent destine a etre utilise dans une chirurgie de detachement de membrane intraoculaire
CN114748682A (zh) * 2022-04-26 2022-07-15 深圳湾实验室 用于制备烧创伤敷料的组合物及其制剂和制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060069018A1 (en) * 2002-10-10 2006-03-30 Ono Pharmaceutical Co., Ltd. Endogenous repair factor production promoters
WO2008063569A1 (fr) * 2006-11-16 2008-05-29 Coapt Systems, Inc. Matériau d'implant en co-mélange de graisse humaine et de suspension de gel et procédé correspondant
WO2010026299A1 (fr) * 2008-09-08 2010-03-11 Timo Ylikomi Procédés et moyens de synthèse par ingénierie médicale de tissu mou
WO2012024072A1 (fr) * 2010-08-19 2012-02-23 Allergan, Inc. Compositions à base de tissu adipeux et d'un analogue de la pge2 et leur utilisation dans le traitement d'une affection d'un tissu mou

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4756911A (en) 1986-04-16 1988-07-12 E. R. Squibb & Sons, Inc. Controlled release formulation
US5378475A (en) 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
US5869079A (en) 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
US6199076B1 (en) 1996-10-02 2001-03-06 James Logan Audio program player including a dynamic program selection controller
TWI249520B (en) 1998-07-15 2006-02-21 Ono Pharmaceutical Co 5-Thia-omega-substituted phenyl prostaglandin E derivatives, method for producing the same and medicines containing the same as the active ingredient
US20080299213A2 (en) 1999-11-05 2008-12-04 Donald Kleinsek Augmentation and repair of spincter defects with cells including adipocytic cells
US6673285B2 (en) 2000-05-12 2004-01-06 The Regents Of The University Of Michigan Reverse fabrication of porous materials
FR2811996B1 (fr) 2000-07-19 2003-08-08 Corneal Ind Reticulation de polysaccharide(s), preparation d'hydrogel(s) ; polysaccharide(s) et hydrogel(s) obtenus,leurs utilisations
KR20030053063A (ko) 2000-11-27 2003-06-27 화이자 프로덕츠 인코포레이티드 골다공증 치료용 이피4 수용체 선택성 작용제
KR20070043059A (ko) 2001-07-23 2007-04-24 오노 야꾸힝 고교 가부시키가이샤 Ｅｐ４ 아고니스트를 유효 성분으로 하는 골량 저하 질환의치료제
US20040254230A1 (en) 2001-12-03 2004-12-16 Ogidigben Miller J. Method for treating ocular hypertension
US7651684B2 (en) 2001-12-07 2010-01-26 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in augmenting autologous fat transfer
US7855226B2 (en) 2003-02-11 2010-12-21 Allergan, Inc. Treatment of inflammatory bowel disease
US6875787B2 (en) 2003-02-11 2005-04-05 Allergan, Inc. 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure
WO2004073759A1 (fr) 2003-02-19 2004-09-02 Aventis Pharmaceuticals Holdings Inc. Composition et methode pour augmenter le tissu mou intradermique
EP3231846A1 (fr) 2003-04-10 2017-10-18 Tufts University Solution aqueuse concentrée de fibroïne de soie et son utilisation
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
EP1670385B1 (fr) 2003-10-01 2013-01-23 University of Washington Nouveaux biomateriaux poreux
CN100548271C (zh) 2004-01-20 2009-10-14 阿勒根公司 用于眼部的局部治疗、并优选包括有曲安奈德及透明质酸的组合物
US7799336B2 (en) 2004-04-30 2010-09-21 Allergan, Inc. Hypotensive lipid-containing biodegradable intraocular implants and related methods
WO2006016695A1 (fr) 2004-08-10 2006-02-16 Ono Pharmaceutical Co., Ltd. Prévention et/ou remède pour hyperpotassémie contenant un agoniste ep4
FR2878444B1 (fr) 2004-11-30 2008-04-25 Corneal Ind Soc Par Actions Si Solutions viscoelastiques renfermant du hyaluronate de sodiu et de l'hydroxypropylmethylcellulose, preparation et utilisations
JP4985400B2 (ja) 2005-06-24 2012-07-25 大正製薬株式会社 プロスタグランジン誘導体
US20070036844A1 (en) 2005-08-01 2007-02-15 Ma Peter X Porous materials having multi-size geometries
WO2008092861A1 (fr) 2007-01-30 2008-08-07 Janssen Pharmaceutica N.V. Dérivés bicycliques utilisés comme agonistes de ep4
WO2008092862A1 (fr) 2007-01-30 2008-08-07 Janssen Pharmaceutica N.V. Dérivés bicycliques utilisés comme agonistes de ep4
WO2008092860A1 (fr) 2007-01-30 2008-08-07 Janssen Pharmaceutica N.V. Dérivés bicycliques comme agonistes de ep4
WO2008103807A2 (fr) 2007-02-21 2008-08-28 Cedars-Sinai Medical Center Méthodes de production de préadipocytes et d'augmentation de la prolifération de cellules souches/progénitrices adipeuses adultes
BRPI0811306A2 (pt) 2007-05-08 2015-01-27 Nat Univ Corp Hamamatsu Ativador de célula t citotóxica compreendendo agonista ep4
GB0810615D0 (en) 2008-06-10 2008-07-16 Glaxo Group Ltd Novel pharmaceutical
US8450475B2 (en) 2008-08-04 2013-05-28 Allergan, Inc. Hyaluronic acid-based gels including lidocaine

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060069018A1 (en) * 2002-10-10 2006-03-30 Ono Pharmaceutical Co., Ltd. Endogenous repair factor production promoters
WO2008063569A1 (fr) * 2006-11-16 2008-05-29 Coapt Systems, Inc. Matériau d'implant en co-mélange de graisse humaine et de suspension de gel et procédé correspondant
WO2010026299A1 (fr) * 2008-09-08 2010-03-11 Timo Ylikomi Procédés et moyens de synthèse par ingénierie médicale de tissu mou
WO2012024072A1 (fr) * 2010-08-19 2012-02-23 Allergan, Inc. Compositions à base de tissu adipeux et d'un analogue de la pge2 et leur utilisation dans le traitement d'une affection d'un tissu mou

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BAUER-KREISEL P ET AL: "Cell-delivery therapeutics for adipose tissue regeneration", ADVANCED DRUG DELIVERY REVIEWS, ELSEVIER BV, AMSTERDAM, NL, vol. 62, no. 7-8, 15 June 2010 (2010-06-15), pages 798 - 813, XP027473661, ISSN: 0169-409X, [retrieved on 20100413], DOI: 10.1016/J.ADDR.2010.04.003 *
HEMMRICH ET AL: "Autologous In Vivo Adipose Tissue Engineering in Hyaluronan-Based Gels-A Pilot Study", JOURNAL OF SURGICAL RESEARCH, ACADEMIC PRESS INC., SAN DIEGO, CA, US, vol. 144, no. 1, 11 December 2007 (2007-12-11), pages 82 - 88, XP022385921, ISSN: 0022-4804, DOI: 10.1016/J.JSS.2007.03.017 *

Also Published As

Publication number Publication date
CA2827615A1 (fr) 2012-08-23
AU2012217630A1 (en) 2013-09-05
WO2012112757A2 (fr) 2012-08-23
EP2675491A2 (fr) 2013-12-25
BR112013021035A2 (pt) 2016-10-11

Similar Documents

Publication Publication Date Title
EP3285688A4 (fr) Implants cornéens
EP2538988A4 (fr) Procédé de décellularisation de tissu
EP2531138A4 (fr) Implants intraoculaires, et kits et procédés associés
WO2012149472A9 (fr) Procédés, compositions et trousses pour traiter et prévenir des états neurologiques
EP2714081A4 (fr) Méthodes, compositions et trousses pour le traitement du cancer
EP2739237A4 (fr) Instrument chirurgical et son procédé de commande
EP2757999A4 (fr) Implant de tissu dur
EP3494922C0 (fr) Procédé de fabrication de prothèses partielles ou totales
HUE040412T2 (hu) Fúróimplantátum-sebészethez
BR112014004192A2 (pt) composição de tratamento de sementes, e, método de tratamento de sementes
GB201305198D0 (en) Kits, components and methods for tissue reconstruction
HK1201213A1 (en) Nonaqueous compositions for bone hemostasis, and methods for their use and manufacture
EP2680787A4 (fr) Implant chirurgical et procédé associé
WO2013023151A3 (fr) Compositions et méthodes de traitement de maladie cœliaque
EP2827783A4 (fr) Prothèse implantable pour réparation de tissu mou
EP2903537A4 (fr) Suture pour réparation de tissu mou
WO2012097272A8 (fr) Compositions d'hydrogel stable incluant des additifs
GB2505800B (en) Valve body arrangement and method for manufacture thereof as well as valve having the valve body arrangement
EP2681280A4 (fr) Biomatériau, procédé de fabrication du biomatériau et ses utilisations
EP2732068B8 (fr) Procédé pour améliorer la résistance à l'usure d'instruments chirurgicaux colorés
WO2012112757A3 (fr) Compositions et procédés améliorés de remplacement de tissu mou
KR101468123B9 (ko) 탯줄 유래 줄기세포를 포함하는 근위축 질환 개선 또는 치료용 조성물
WO2013038269A3 (fr) Appareil et procédés permettant de traiter des morceaux de tiges de canne à sucre
EP2563120A4 (fr) Méthodes, compositions et kits de traitement thérapeutique
EP2623655A4 (fr) Cuir artificiel et son procédé de fabrication

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12708198

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2827615

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2012217630

Country of ref document: AU

Date of ref document: 20120216

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2012708198

Country of ref document: EP

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112013021035

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112013021035

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20130816